A case of disseminated Mycobacterium bovis 2 years post-intravesicular Bacillus Calmette-Guérin therapy for superficial urinary bladder cancer

Intern Med J. 2017 Jul;47(7):820-823. doi: 10.1111/imj.13475.

Abstract

Disseminated Mycobacterium bovis is an uncommon side-effect of intravesical Bacillus Calmette-Guérin (BCG) therapy that may be mediated through Mycobacteraemia. This case report, of a 77-year-old man with a history of intravesical BCG therapy and recent cardiac surgery, highlights the need for patients with similar features on history, presenting with generalised symptoms, to have mycobacterial cultures included in their workup.

Keywords: general medicine; infectious disease; oncology; urology.

Publication types

  • Case Reports

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / adverse effects
  • Administration, Intravesical
  • Aged
  • BCG Vaccine / administration & dosage
  • BCG Vaccine / adverse effects*
  • Humans
  • Male
  • Mycobacterium bovis / isolation & purification*
  • Time Factors
  • Tuberculosis / chemically induced*
  • Tuberculosis / diagnosis
  • Tuberculosis / etiology
  • Urinary Bladder Neoplasms / complications
  • Urinary Bladder Neoplasms / diagnosis
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Adjuvants, Immunologic
  • BCG Vaccine